| Financial Year |
March 31 2023 |
| Monetary Funds |
746,942,400.01 |
| Held-for-trading Financial Assets |
194,525,348.36 |
| Notes Receivable |
230,560,601.76 |
| Accounts Receivable |
1,288,969,095.62 |
| Advances to Suppliers |
376,712,793.19 |
| Other Receivables |
140,636,266.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
628,233,968.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
84,714,675.12 |
| Total Current Assets |
3,708,006,132.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
171,977,039.04 |
| Investment Properties |
4,498,064.55 |
| Fixed Assetes |
484,623,612.18 |
| Under-construction Projects |
193,626,814.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,096,231.94 |
| R&D expenses |
11,505,386.40 |
| Goodwill |
6,538,611.62 |
| Long-Term Deferred and Prepaid Expenses |
9,770,625.30 |
| Deferred Income Tax Assets |
10,317,628.05 |
| Other Non-Current Assets |
120,749,311.04 |
| Sub-Total of Non-Current Assets |
1,349,355,877.56 |
| Total Assets |
5,057,362,009.89 |
| Short-Term Loans |
992,194,390.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
600,291,372.53 |
| Accounts Payable |
429,383,901.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,451,863.44 |
| Taxes Payable |
31,606,892.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
63,667,382.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,000,000.00 |
| Other Current Liabilities |
59,413,989.77 |
| Sub-Total of Current Liabilities |
2,292,100,928.45 |
| Long-term Loans |
308,960,236.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
87,174,777.59 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,550,164.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
439,898,169.21 |
| Total Liabilities |
2,731,999,097.66 |
| Paid-In Capital(Or Share Stock) |
585,216,422.00 |
| Capital Surplus |
682,378,451.63 |
| Surplus Reserve |
110,903,105.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
898,238,087.84 |
| Minority Stockholder's Interest |
6,039,572.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,319,323,339.97 |
| Owner's Equity（Stockholder's Equity） |
2,325,362,912.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,057,362,009.89 |
